397 related articles for article (PubMed ID: 8377223)
1. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
Panagopoulos NT; Matsokis NA; Valcana T
J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
[TBL] [Abstract][Full Text] [Related]
2. Kinetic and pharmacologic characterization of dopamine binding in the mouse cerebellum and the effects of the reeler mutation.
Panagopoulos N; Matsokis NA; Valcana T
J Neurosci Res; 1988; 19(1):122-9. PubMed ID: 3343704
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice.
Efthimiopoulos S; Giompres P; Valcana T
J Neurosci Res; 1991 Aug; 29(4):510-9. PubMed ID: 1838778
[TBL] [Abstract][Full Text] [Related]
4. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
[TBL] [Abstract][Full Text] [Related]
5. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
6. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
7. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
8. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.
Rubinstein M; Muschietti JP; Gershanik O; Flawia MM; Stefano FJ
J Pharmacol Exp Ther; 1990 Feb; 252(2):810-6. PubMed ID: 2138223
[TBL] [Abstract][Full Text] [Related]
9. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
Levant B; DeSouza EB
Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762
[TBL] [Abstract][Full Text] [Related]
10. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
11. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
12. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites.
Severson JA; Randall PK
J Pharmacol Exp Ther; 1985 May; 233(2):361-8. PubMed ID: 3158731
[TBL] [Abstract][Full Text] [Related]
13. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
14. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
Srivastava LK; Mishra RK
Biochem Int; 1990; 21(4):705-14. PubMed ID: 2241996
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
17. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
18. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptors increase in the dorsolateral striatum of weaver mutant mice.
Kaseda Y; Ghetti B; Low WC; Richter JA; Simon JR
Brain Res; 1987 Sep; 422(1):178-81. PubMed ID: 2960423
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in striatal dopamine D2 receptor binding in weaver mice and effects of ventral mesencephalic grafts.
Kaseda Y; Ghetti B; Low WC; Norton J; Brittain H; Triarhou LC; Richter JA; Simon JR
Exp Brain Res; 1990; 83(1):1-8. PubMed ID: 2150046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
